EpCAM-AF680 NIRF imaging enables evaluation of treatment response in clinically relevant endometrial carcinoma PDX models and may facilitate translational studies of new targeted treatments and corresponding response predicting markers. This evidence concerns the gene EPCAM and endometrial carcinoma.